A Landmark Update: ASH and ISTH Release First Pediatric VTE Guidelines Since 2018
The International Society on Thrombosis and Haemostasis (ISTH) shared a proud post on X:
”Check it out! The American Society of Hematology (ASH) and ISTH Updated Guidelines on the Treatment of Pediatric VTE are featured in Hematology Advisor. Don’t miss this spotlight on our collaborative effort!
”
Read the full feature here.
‘These evidence-based guidelines are a key resource for clinicians to improve the quality of care for this vulnerable population,” said ASH President Belinda R. Avalos, MD.
ASH and ISTH have jointly published updated clinical guidelines for the management of pediatric venous thromboembolism (VTE), featured in Blood Advances.
These new recommendations reflect the latest evidence since ASH’s last update in 2018.
Developed by a multidisciplinary panel, the guidelines address critical aspects of pediatric VTE care—including decisions about whether to initiate treatment, management of acute thrombosis, and tailoring therapy to specific clinical scenarios.
In total, 16 recommendations were revised, and 4 new ones were introduced.
The updated guidelines represent a significant step forward in standardizing and advancing pediatric thrombosis care globally!
Latest advancements in hematology featured in Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia